A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years
Clinical trial NCT01389596 · COMPLETED
Trial details
- NCT number
- NCT01389596
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-27
- Primary completion
- 2016-08-10
- Enrollment
- 295
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.